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Aim: A literature review was undertaken to identify current TSEB therapy in pediatric
patients.
Background: Total skin electron beam (TSEB) therapy is a method of irradiation with low
energy electron beam dedicated to patients who have superﬁcial skin lesions all over their
body. Such skin malignancies are sparse among adults and even more uncommon with
pediatric population.
Materials and methods: In this study, all reported case reports were summed up with a special
emphasis on techniques used, doses prescribed and special shielding of critical organs.
Moreover, potential problems that were encountered during TSEB irradiation of very young
patients were depicted.
Results: The literature has described only seven case reports of children undergoing TSEB
therapy. Most of them were infants; however, two adolescents were also treated. For all
infants, general anesthesia was provided to allow safe and accurate TSEB irradiation. The
prescribed dose varied from 16 Gy to 28 Gy depending on the irradiation schedule and patient
condition. Usually, boost ﬁelds were applied to the scalp and perineum. Typical shields for
ﬁngernails, toenails and lenses were usually used.Conclusion: This paper revealed that TSEB therapy may be considered as a palliative treat-
ment for pediatric patients with leukemia cutis. However, its role is still unclear and should
be  further investigated.
© 2013 Greater Poland Cancer Centre. Published by Elsevier Urban & Partner Sp. z o.o. All
rights reserved.
a rapid fall off after reaching its “peak” at a shallow depth..  Backgroundhe idea of total skin electron beam (TSEB) therapy is to deliver
 prescribed dose only to the patient’s skin and to protect
s much as possible healthy tissues inside the body. Electron
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This technique has been used for adults for many  years to
treat rare skin diseases such as mycosis fungoides, Sezary syn-
drome or Kaposi sarcoma3–8; however, it is uncommon in the
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pediatric population. Many  various techniques of TSEB ther-
apy for adults have been described in the literature1,9–13 and
lately two large reviews of all current techniques have been
published by Diamantopoulos et al.14 and Piotrowski et al.15
TSEB therapy is also used to treat pediatric patients with
leukemia cutis (LC). LC, also called a cutaneous granulocytic
sarcoma, is a term for an extramedullary leukemia where
malignant leukocytes inﬁltrate into the skin16. The disease
manifests with widespread bluish purple papules, nodules
or plaques17. They may be different in size and appear on
patient’s face, legs, arms and trunk18,19. LC is a very rare dis-
ease and usually associated with poor prognosis20. It can occur
before or after establishment of systemic leukemia and is
more  common in children than adults16.
Literature on TSEB for pediatric patients is very limited
and mostly described in brief case reports20–24. The ﬁrst such
description for a pediatric patient with LC was made by Rubin
et al.21 in 1985. Then in 1995, a detailed paper was pub-
lished by Earley et al.22 where the whole TSEB procedure for
infants was depicted. In 2007, two more  case reports were pre-
sented by Pepek et al.23 Lately, Bao et al.24 provided a report
for a commissioning and quality assurance method of imple-
menting TSEB therapy to a sedated infant, and Majd et al.20
provided another case report on LC treated with TSEB ther-
apy. Although new technologies have revolutionized the ﬁeld
of radiation oncology,25–28 the TSEB irradiation of children has
not changed so much since 1985.
1.1.  Aim
The purpose of this study is to summarize the techniques
applied in TSEB therapy for pediatric patients with LC and
to report about common methods as well as potential prob-
lems of such therapy and how they have been solved in the
literature.
2.  Patients
To the best of my  knowledge, only seven pediatric patients
treated with TSEB have been reported in the literature.
Most of them were infants (median age 14 months, range
12–17 months) and two patients were 13 and 18 years old.
Among this group, there were three males and two females.
The sex of two patients was not reported. The disease mani-
fested with raised, violaceous nodules on the scalp, face, arms
and back. Skin biopsy was done in all cases, LC was conﬁrmed
and TSEB treatment offered.
3.  Techniques  of  irradiation
TSEB therapy has a long history in treating skin diseases. There
are three main techniques of TSEB irradiation that have been
well described in the literature.29,30 Apart from them, there
are many  modiﬁed techniques that are combinations of the
above mentioned ones. All modiﬁed techniques are well sum-
marized in the paper by Diamantopoulos et al.14
For children, the most popular TSEB was a modiﬁed Stan-
ford technique which was applied in four out of seven patients.
In a paper presented by Pepek et al.,23 a rotational TSEBiotherapy 1 9 ( 2 0 1 4 ) 109–113
technique was used, while Rubin et al.21 used a multiple-
ﬁeld pendulum-arc technique. In the two cases described by
Pepek et al.,23 utilizing a rotational technique was possible as
the patients were 13 and 18 years old. Thus, it was possible
for them to stand on a spinning platform during irradiation
with electrons. The rest of the patients were infants that were
not able to stand on their own during the treatment. For this
reason, some children20,21,24 were placed in a custom-made
harness which was attached to a special frame. Arm positions
were secured with velcro strips and tape. Earley et al.22 pro-
posed infants to be irradiated in a lying position. The patient
was positioned on a Plexiglas platform that was used for lift-
ing and moving. For anterior and posterior ﬁelds, the child was
irradiated lying on the ﬂoor with gantry angle set at 0◦. For
oblique ﬁelds it was lying on a table with gantry angle set at
60◦. Arms and legs were adjusted appropriately for each ﬁeld.
The source-skin distance (SSD) was set to 200 cm.  Fig. 1 pro-
vides a schematic picture of most popular TSEB techniques
for children. To allow safe and accurate TSEB irradiation for
all infants, general anesthesia was provided.
4.  Dose  prescription
TSEB therapy for children was planned mostly with 6 MeV;
however, Rubin et al.21 used 8 MeV degraded electron ﬁelds.
The prescription doses varied from 16 Gy to 28 Gy. The irradia-
tion schedule differed across radiotherapy centers and patient
conditions (Table 1).
Additional boost ﬁelds were added to irradiate areas that
received low doses from a normal TSEB treatment. Usually,
boost ﬁelds were applied to the scalp and perineum. A boost
dose can be assessed based on the underdosage of each region
during a main TSEB treatment. Only in one case,24 a bolus of
1 cm was used to boost the top of the head with 6 MeV elec-
tron beam energy. In the other case reports, no bolus was used
during the treatment.
5.  Shields
During TSEB therapy for children, some parts of the body
should be shielded. This applies mostly to ﬁnger tips and
toes since those areas are very thin and can experience much
higher dose than the rest of the skin. Another organ that may
be shielded during TSEB therapy are lenses since they are very
sensitive to radiation dose. Depending on the degree of skin
involvement, shields are included throughout or during part
of the treatment course.
Pepek et al.23 reported that eye shields were used for both
patients throughout the treatment. Fingernails as well as toe-
nails were also covered during the whole TSEB therapy for one
of the patients (the younger one). The other patient received
shielding of the nails after 12 Gy. Majd et al.20 used only shields
for ﬁngernails. An interesting shielding was provided by Earley
et al.22 Beside external eye shields, special wax compensators
around hands and feet were attached with lead shields for nail
beds. Since the volume of infant’s hand and foot is very small,
the danger of overdosage to those areas is highly probable. For
this reason, extra wax was added until the ﬁst and foot had
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Fig. 1 – The most popular patient positioning for total skin electron beam therapy for children: (1) rotational technique –
possible only for children who  can stand on their own; (2) modiﬁed Stanford technique in vertical position – the infant was
placed in a custom made harness attached to a special frame; (3) modiﬁed Stanford technique in horizontal position: (3a)
treatment of the anterior and posterior ﬁelds – the gantry is set at 0◦ (3b) treatment of the oblique ﬁelds – the gantry is
rotated 60◦ off vertical. For (2) and (3) arms were  positioned to match  the standard positioning.
Table 1 – Published case series of TSEB therapy for pediatric patients.
References Age Sex Total dose [Gy] Fractionation Local boost
Rubin et al. [21] 13 months Female 19 1.12 Gy/fx 12 Gy to perineun
(3 Gy/fx)
Earley et al. [22] 14 months Male 28 2 Gy/fx (2 treatments
per week)
Not  reported
Pepek et al. [23] 13 years Male 16 2  Gy/fx (3 treatments
per week)
6  Gy to scalp (2 Gy/fx)
18 years Male 18 None
Bao et al. [24] 17 months Not reported 16 2  Gy/cyclea (2 days
per cyclea)
None
12 months 16 To scalp (dose not
reported)
Majd et al. [20] 15 months Female 16 To perineum and
plantar surfaces (dose
not reported)
a Each cycle consists of 2 treatment days with 3 dual ﬁelds each.
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diameters of at least 5 cm.  The authors showed that this is the
minimum thickness that should be provided to prevent high
doses.
6.  Potential  problems
TSEB therapy for children can be administered without prob-
lems to adolescents as described by Pepek et al.,23 because
the patient can stand on their own and cooperate with the
radiotherapy staff. The problem begins when a very young
pediatric patient has to be irradiated. The most difﬁcult part
was to set up an infant for the time of treatment. In all cases
where infants underwent TSEB therapy, the staff decided that
anesthesia was necessary for proper immobilization. Due to
this fact, the vital signs of the patient had to be monitored;
however, the staff should always remember that such equip-
ment should not shield the skin of the patient. To smear out
the shielding effect of blood pressure cuff, it should be placed
in different positions during the course of treatment.24
The infants were mostly irradiated in a custom made har-
ness attached to a specially constructed frame.20,21,24 As a
result, the child was suspended above the ﬂoor and its trunk
was rotated from above when necessary with arms positioned
using velcro strips and tape as in the Stanford technique. In
this setup, the harness covers the whole trunk and should
be made from a fabric that does not attenuate the electron
beam while being able to support the child. This problem does
not exist when an infant is irradiated in a lying position as
described by Earley et al.22 In such case, the patient is naked,
so, to maintain the body’s temperature, a heat lamp should be
present (outside the treatment ﬁeld).
TSEB therapy in the case of infants brings also the problem
of overdosage in very small volumes such as ﬁngers and toes.
Earley et al.22 measured dose uniformity with thermolumi-
nescent dosimeters (TLDs) and specially designed phantoms
of different sizes, their diameters ranging from 1 cm to 7.5 cm.
The results showed that the dose to the smallest phantom was
approximately 4 times higher than that delivered to the skin
of the trunk. The overdosage of small body parts can cause a
bone growth disorder resulting in structural asymmetry. As a
result, they suggested that any body part that is smaller than
5 cm in diameter should be compensated with wax.
7.  Toxicity
TSEB therapy was always well tolerated by the patients.
However, some mild skin toxicity appeared – it consisted of
hyperpigmentation, dryness and minimal erythema. Only for
one case, desquamation was reported.21 Pepek et al.23 noted
that one of the patients developed grade 2 oral mucositis.
Moreover, a mild fatigue could often be observed during the
treatment.
8.  Results  of  the  treatmentIn most publications regarding TSEB therapy for children,
a signiﬁcant improvement in skin lesions was noticed.20–23
Rubin et al.21 reported that all skin nodules disappeared andiotherapy 1 9 ( 2 0 1 4 ) 109–113
12 months after the treatment the child remained in com-
plete remission. Earley et al.22 noted that 3 months after TSEB
therapy the skin remained free of disease and healthy in
appearance. However, the child relapsed of his initial disease
so the prognosis was poor. Signiﬁcant improvement of the skin
lesions after TSEB treatment was also reported by Pepek et al.23
Both patients did not develop any skin recurrence after 4 and
19.5 months after TSEB therapy, respectively, before dying due
to complications of sepsis. A relapse of initial disease during
the course of treatment was noted by Majd et al.20 Although,
radiation therapy improved skin lesions, the infant died due
to leukemia progression.
9.  Conclusions
All case reports mentioned that improvement of patient’s skin
lesions and nodules could be observed after TSEB therapy.
Unfortunately, most of these patients died from sepsis after
bone marrow transplant or due to the relapse of the initial
disease in the bone marrow. However, based on the published
case reports, one may assume that TSEB therapy might be used
as a palliative treatment of young patients with LC.
Further data are needed to verify if TSEB therapy affects
overall survival for pediatric patients. Moreover, before such
treatment, one has to consider the long-term toxicity since
tolerance for irradiation of total skin in very young patients is
still unknown.
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